BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 982004)

  • 1. [Prognostic factors concerning the survival time of Hodgkin's disease stage III and IV, treated with cytostatic agents].
    Stoller U; Brunner K
    Schweiz Med Wochenschr; 1976 Apr; 106(15):507-13. PubMed ID: 982004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis of lymphogranulomatosis (stage III B-IV) treated with drugs--results of a retrospective 10 year study].
    Hochheim D; Fink R; Hanzl J; Höche D; Rüdiger KD; Wutke K; Anger G
    Z Gesamte Inn Med; 1979 Jul; 34(14):178-80. PubMed ID: 538992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
    Smolewski P; Robak T; Krykowski E; Blasiñska-Morawiec M; Niewiadomska H; Pluzanska A; Chmielowska E; Zambrano O
    Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study.
    Fermé C; Bastion Y; Brice P; Lederlin P; Diviné M; Gabarre J; Assouline D; Ferrant A; Berger F; Lepage E
    Cancer; 1997 Sep; 80(6):1124-33. PubMed ID: 9305714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
    Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
    Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship between several prognostic factors in Hodgkin's disease.
    Kotlarek-Haus S; Gabryś K; Starzyk H; Sciborski R; Gałazka Z
    Arch Geschwulstforsch; 1982; 52(4):293-301. PubMed ID: 7138241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alkaline phosphatase as a prognostic factor in Hodgkin's disease].
    Avilés A; Talavera A; García EL; Guzmán R; Díaz-Maqueo JC
    Rev Gastroenterol Mex; 1990; 55(4):211-4. PubMed ID: 2091188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral centre.
    Chandi L; Kumar L; Kochupillai V; Dawar R; Singh R
    Natl Med J India; 1998; 11(5):212-7. PubMed ID: 10997167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD).
    Gobbi PG; Comelli M; Grignani GE; Pieresca C; Bertoloni D; Ascari E
    Haematologica; 1994; 79(3):241-55. PubMed ID: 7926973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
    Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
    Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease. Results from a program in radiation therapy.
    Micaily B; Brady LW
    Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
    J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelioid granulomas in Hodgkin's disease--prognostic significance.
    Chopra R; Rana R; Zachariah A; Mahajan MK; Prabhakar BR
    Indian J Pathol Microbiol; 1995 Oct; 38(4):427-33. PubMed ID: 9726157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.